Advertisement

Perioperative duloxetine administration reduces pain after high tibial osteotomy and non-steroidal anti-inflammatory administration: A prospective, controlled study

      Highlights

      • Duloxetine is a potent selective serotonin norepinephrine reuptake inhibitor.
      • A prospective clinical trial investigated whether duloxetine reduces postoperative knee pain.
      • Duloxetine administration showed good outcomes after high tibial osteotomy.
      • Postoperative non-steroidal anti-inflammatory drug use was significantly reduced.

      Abstract

      Background

      Postoperative pain management is essential for patient satisfaction; however, no reports have described the effect of perioperative duloxetine administration on the postoperative pain management following knee surgery. This study aimed to determine whether perioperative duloxetine administration reduces pain following high tibial osteotomy.

      Methods

      In this prospective clinical trial, 35 and 33 patients receiving (40 mg/day) and not receiving duloxetine (control), respectively were enrolled. The knee pain and quality of recovery were evaluated using the numeric rating scale (NRS) scores, the frequency of analgesic drugs used, and patient-reported outcome measures, including the NRS score at rest and the Knee Injury and Osteoarthritis Outcome Score (KOOS), were compared between the groups.

      Results

      The NRS scores of the duloxetine group (D) were significantly reduced compared with those of the control group (C) on postoperative day 1 (D:3.8 vs C:5.1, p = 0.022), day 7 (D:2.1 vs C:2.9, p = 0.021), and day 14 (D:1.6 vs C:2.9, p = 0.001). Non-steroidal anti-inflammatory drug administration was significantly lower in the duloxetine group than in the control group (p < 0.001). Although the KOOS score was not significantly different in several subcategories at the pre- and postoperative time-points, the Function in Sport subcategory of the KOOS was significantly improved in the duloxetine group compared with that in the control group at 3 months postoperatively (p < 0.05).

      Conclusion

      Perioperative use of duloxetine from 2 weeks before surgery to 2 weeks after surgery is advantageous in perioperative pain management and KOOS improvement following high tibial osteotomy.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Knee
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hantes M.E.
        • Natsaridis P.
        • Koutalos A.A.
        • Ono Y.
        • Doxariotis N.
        Malizos KN Satisfactory functional and radiological outcomes can be expected in young patients under 45 years old after open wedge high tibial osteotomy in a long-term follow-up.
        Knee Surg Sports Traumatol Arthrosc. 2018; 26: 3199-3205https://doi.org/10.1007/s00167-017-4816-z
        • Hui C.
        • Salmon L.J.
        • Kok A.
        • Williams H.A.
        • Hockers N.
        • van der Tempel W.M.
        • et al.
        Long-term survival of high tibial osteotomy for medial compartment osteoarthritis of the knee.
        Am J Sport Med. 2011; 39: 64-70https://doi.org/10.1177/0363546510377445
        • Lobenhoffer P.
        • Agneskirchner J.D.
        Improvements in surgical technique of valgus high tibial osteotomy.
        Knee Surg Sports Traumatol Arthrosc. 2003; 11: 132-138https://doi.org/10.1007/s00167-002-0334-7
        • Neirynck J.
        • van Beek N.
        • Claes T.
        • Claes S.
        • Bartholomeeusen S.
        Simultaneous bilateral opening-wedge high tibial osteotomy with structural allograft impaction results in excellent early recovery and pain reduction similar unilateral osteotomy.
        Knee. 2021; 30: 283-290https://doi.org/10.1016/j.knee.2021.04.016
        • Sim J.A.
        • Lee M.G.
        • Jung W.S.
        • Lee B.K.
        • Lee B.H.
        Clinical efficacy of adductor canal block in medial open wedge high tibial osteotomy.
        Knee. 2021; 29: 9-14https://doi.org/10.1016/j.knee.2020.12.017
        • Chang C.B.
        • Cho W.S.
        Pain management protocols, peri-operative pain and patient satisfaction after total knee replacement: a multicentre study.
        J Bone Joint Surg Br. 2012; 94: 1511-1516https://doi.org/10.1302/0301-620X.94B11.29165
        • Sinatra R.S.
        • Torres J.
        • Bustos A.M.
        Pain management after major orthopaedic surgery: current strategies and new concepts.
        J Am Acad Orthop Surg. 2002; 10: 117-129https://doi.org/10.5435/00124635-200203000-00007
        • Marks D.M.
        • Shah M.J.
        • Patkar A.A.
        • Masand P.S.
        • Park G.Y.
        • Pae C.U.
        Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise.
        Curr Neuropharmacol. 2009; 7: 331-336https://doi.org/10.2174/157015909790031201
        • Chappell A.S.
        • Ossanna M.J.
        • Liu-Seifert H.
        • Iyengar S.
        • Skljarevski V.
        • Li L.C.
        • et al.
        Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial.
        Pain. 2009; 146: 253-260https://doi.org/10.1016/j.pain.2009.06.024
        • Frakes E.P.
        • Risser R.C.
        • Ball T.D.
        • Hochberg M.C.
        • Wohlreich M.M.
        Duloxetine added to oral nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: results of a randomized, double-blind, placebo-controlled trial.
        Curr Med Res Opin. 2011; 27: 2361-2372https://doi.org/10.1185/03007995.2011.633502
        • YaDeau J.T.
        • Brummett C.M.
        • Mayman D.J.
        • Lin Y.
        • Goytizolo E.A.
        • Padgett D.E.
        • et al.
        Duloxetine and Subacute Pain after Knee Arthroplasty when Added to a Multimodal Analgesic Regimen: A Randomized, Placebo-controlled, Triple-blinded Trial.
        Anesthesiology. 2016; 125: 561-572https://doi.org/10.1097/ALN.0000000000001228
        • Ho K.Y.
        • Tay W.
        • Yeo M.C.
        • Liu H.
        • Yeo S.J.
        • Chia S.L.
        • et al.
        Duloxetine reduces morphine requirements after knee replacement surgery.
        Br J Anaesth. 2010; 105: 371-376https://doi.org/10.1093/bja/aeq158
        • Enomoto H.
        • Fujikoshi S.
        • Ogawa K.
        • Tsuji T.
        • Tanaka S.
        Relationship Between Pain Reduction and Improvement in Health-Related Quality of Life in Patients with Knee Pain Due to Osteoarthritis Receiving Duloxetine: Exploratory Post Hoc Analysis of a Japanese Phase 3 Randomized Study.
        J Pain Res. 2020; 13: 181-191https://doi.org/10.2147/JPR.S211072
        • Koh I.J.
        • Kim M.S.
        • Sohn S.
        • Song K.Y.
        • Choi N.Y.
        • In Y.
        Duloxetine Reduces Pain and Improves Quality of Recovery Following Total Knee Arthroplasty in Centrally Sensitized Patients: A Prospective, Randomized Controlled Study.
        J Bone Joint Surg Am. 2019; 101: 64-73https://doi.org/10.2106/JBJS.18.00347
        • Otsuki S.
        • Murakami T.
        • Okamoto Y.
        • Nakagawa K.
        • Okuno N.
        • Wakama H.
        • et al.
        Hybrid high tibial osteotomy is superior to medial opening high tibial osteotomy for the treatment of varus knee with patellofemoral osteoarthritis.
        Knee Surg Sports Traumatol Arthrosc. 2019; 27: 1332-1338https://doi.org/10.1007/s00167-018-5015-2
        • Mayer T.G.
        • Neblett R.
        • Cohen H.
        • Howard K.J.
        • Choi Y.H.
        • Williams M.J.
        • et al.
        The development and psychometric validation of the central sensitization inventory.
        Pain Pract. 2012; 12: 276-285https://doi.org/10.1111/j.1533-2500.2011.00493.x
        • Sullivan M.J.L.
        • Bishop S.R.
        • Pivik J.
        The Pain Catastrophizing Scale: Development and Validation.
        Psychol Assess. 1995; 7: 524-532
        • Cleeland C.S.
        • Ryan K.M.
        Pain assessment: global use of the Brief Pain Inventory.
        Ann Acad Med Singap. 1994; 23: 129-138
        • Yoshida K.
        • Sekiguchi M.
        • Otani K.
        • Mashiko H.
        • Shiota H.
        • Wakita T.
        • et al.
        A validation study of the Brief Scale for Psychiatric problems in Orthopaedic Patients (BS-POP) for patients with chronic low back pain (verification of reliability, validity, and reproducibility).
        J Orthop Sci. 2011; 16: 7-13https://doi.org/10.1007/s00776-010-0012-4
        • Summers S.
        • Mohile N.
        • McNamara C.
        • Osman B.
        • Gebhard R.
        • Hernandez V.H.
        Analgesia in Total Knee Arthroplasty: Current Pain Control Modalities and Outcomes.
        J Bone Joint Surg Am. 2020; 102: 719-727https://doi.org/10.2106/JBJS.19.01035
        • Brouwers H.F.G.
        • de Vries A.J.
        • van Zuilen M.
        • van Kouswijk H.W.
        • Brouwer R.W.
        The role of computer-assisted cryotherapy in the postoperative treatment after total knee arthroplasty: positive effects on pain and opioid consumption.
        Knee Surg Sports Traumatol Arthrosc. 2021; https://doi.org/10.1007/s00167-021-06568-x
        • Minami K.
        • Tamano R.
        • Kasai E.
        • Yama H.
        • Hasegawa M.
        • Shinohara S.
        • et al.
        Effects of duloxetine on pain and walking distance in neuropathic pain models via modulation of the spinal monoamine system.
        Eur J Pain. 2018; 22: 355-369https://doi.org/10.1002/ejp.1125
        • Harirforoosh S.
        • Asghar W.
        • Jamali F.
        Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications.
        J Pharm Pharm Sci. 2013; 16: 821-847https://doi.org/10.18433/j3vw2f
        • Kim M.S.
        • Koh I.J.
        • Sung Y.G.
        • Park D.C.
        • Na J.W.
        • In Y.
        Preemptive Duloxetine Relieves Postoperative Pain and Lowers Wound Temperature in Centrally Sensitized Patients Undergoing Total Knee Arthroplasty: A Randomized, Double-Blind.
        Placebo-Controlled Trial J Clin Med. 2021; 10: 2809https://doi.org/10.3390/jcm10132809
        • Kim M.S.
        • Koh I.J.
        • Choi K.Y.
        • Yang S.C.
        • In Y.
        Efficacy of duloxetine compared with opioid for postoperative pain control following total knee arthroplasty.
        PLoS ONE. 2021; 16https://doi.org/10.1371/journal.pone.0253641
        • Rienstra W.
        • Blikman T.
        • Dijkstra B.
        • Stewart R.
        • Zijlstra W.
        • van Raaij T.
        • et al.
        Effect of preoperative duloxetine treatment on postoperative chronic residual pain after total hip or knee arthroplasty: a randomised controlled trial.
        BMJ Open. 2021; 11https://doi.org/10.1136/bmjopen-2021-052944
        • Yuan M.
        • Tang T.
        • Ding Z.
        • Li H.
        • Zhou Z.
        Analgesic effect of perioperative duloxetine in patients after total kneearthroplasty: a prospective, randomized, double-blind, placebo-controlled trial.
        BMC Musculoskelet Disord. 2022; 23: 242https://doi.org/10.1186/s12891-022-05194-z
        • YaDeau J.T.
        • Mayman D.J.
        • Jules-Elysee K.M.
        • Lin Y.
        • Padgett D.E.
        • DeMeo D.A.
        • et al.
        Effect of Duloxetine on Opioid Use and Pain After Total Knee Arthroplasty: A Triple-Blinded Randomized Controlled Trial.
        J Arthroplasty. 2022; 37: S147-S154https://doi.org/10.1016/j.arth.2022.02.022